Skip to main content
. 2015 Jun 26;3(5):E479–E486. doi: 10.1055/s-0034-1392016

Table 2. Results (using baseline estimates of variables).

Strategy Cost ($) Effectiveness (QALY) ICER ($/QALY) over Strategy I
I. Wait & watch 19 251 10.36
II. Resect if operable 32 393  9.95 – 32 054 (Dominated)
III. EUS-FNA + Cytology + CEA 25 841 11.22  6590 (Dominated)
IV. Integrated mutational profiling 19 373 12.33    62 (Preferred)